Results 291 to 300 of about 2,311,261 (354)

Clinical Spectrum and Outcomes of SOX1 Antibody‐Associated Paraneoplastic Neurological Syndromes: A Chinese Cohort Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background SOX1 antibody‐positive paraneoplastic neurological syndromes (PNS) exhibit significant population‐specific clinical heterogeneity. While Western cohorts predominantly manifest Lambert‐Eaton myasthenic syndrome (65%–80%), comprehensive clinical characterization and treatment response data in Asian populations remain critically ...
Jin‐Long Ye, Zu‐Ying Kuang, Bo Li, Meng‐Qiu Pan, Li‐Hua Zhou, Yang‐Yang Dai, Si‐Fen Xie, Xian‐Guang Lin, Ye‐Peng Hu, Li‐Hong Jiang, Zhan‐Hang Wang, Wei‐Jing Zhang   +11 more
wiley   +1 more source

The effect of long-acting cabotegravir and rilpivirine treatment on drug resistance in South Africa: a modelling study. [PDF]

Lancet Glob Health
Han N, Loosli T, Anderegg N, Hauser A, Josi J, Davies MA, Johnson LF, Lessells R, Günthard HF, Egger M, Kouyos RD.   +10 more
europepmc   +1 more source

Molecular Characterization and RIF Resistance Mutation Pattern in Multi Drug Resistance Isolates Using Xpert MTB/RIF Assay in Clinical Isolates from Quetta, Pakistan

Ashraf Ullah Stanikzai, Dr Fazal Rahman Stanikzai   +1 more
openalex   +1 more source

A 73‐Year‐Old Man With Several Years of Difficulty Climbing Stairs and Frequent Tripping

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT A 73‐year‐old man presented with progressive weakness and atrophy predominantly affecting the distal finger flexors and quadriceps muscles. Electrophysiological studies demonstrated mixed myogenic and neurogenic features. Muscle MRI showed inflammatory changes, and muscle biopsy revealed granulomatous myositis with histologic features ...
Mehmet Can Sari, Arens Taga, Sonya Ulrike Steele, Ahmet Hoke   +3 more
wiley   +1 more source

Metabolic Reprogramming: A Crucial Contributor to Anticancer Drug Resistance. [PDF]

MedComm (2020)
Zhu Y, Yan W, Tong L, Yang J, Ge S, Fan J, Jia R, Wen X.   +7 more
europepmc   +1 more source

Utilizing HIV Proviral DNA to Assess for the Presence of HIV Drug Resistance. [PDF]

Clin Infect Dis
Wensing AM, Charpentier C, Calvez V, Ceccherini-Silberstein F, Günthard HF, Jacobsen DM, Paredes R, Shafer RW, Richman DD.   +8 more
europepmc   +1 more source

Overcoming cancer drug resistance through small-molecule targeting of HSP90 and HSP70. [PDF]

Cancer Drug Resist
Cai RD, Lin MJ, Ye QM.
europepmc   +1 more source

NSD2 targeting reverses plasticity and drug resistance in prostate cancer. [PDF]

Nature
Li JJ, Vasciaveo A, Karagiannis D, Sun Z, Gretarsson KH, Chen X, Ouerfelli O, Socciarelli F, Frankenstein Z, Dong H, Zou M, Yuan W, Yang G, Aizenman GM, Pannellini T, Xu X, Beltran H, Chen Y, Gardner K, Robinson BD, de Bono J, Gozani O, Abate-Shen C, Rubin MA, Loda M, Sawyers CL, Califano A, Lu C, Shen MM.   +28 more
europepmc   +1 more source

Targeted drug conjugates and molecular mechanisms in overcoming lung cancer drug resistance. [PDF]

Discov Oncol
Ye L, Xiang S, Xue R, Zhang Y, Wang Y, Xiong X, Qin C, Duan S.   +7 more
europepmc   +1 more source